JP2008510778A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008510778A5 JP2008510778A5 JP2007528960A JP2007528960A JP2008510778A5 JP 2008510778 A5 JP2008510778 A5 JP 2008510778A5 JP 2007528960 A JP2007528960 A JP 2007528960A JP 2007528960 A JP2007528960 A JP 2007528960A JP 2008510778 A5 JP2008510778 A5 JP 2008510778A5
- Authority
- JP
- Japan
- Prior art keywords
- biphenyl
- oxy
- chloro
- fluoro
- propanoic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 18
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 9
- 235000010290 biphenyl Nutrition 0.000 claims description 6
- KOUOVRBERGDLTB-NSHDSACASA-N (2s)-2-[4-chloro-2-(2,5-difluoro-4-morpholin-4-ylsulfonylphenyl)phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C1=CC(F)=C(S(=O)(=O)N2CCOCC2)C=C1F KOUOVRBERGDLTB-NSHDSACASA-N 0.000 claims description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 claims description 3
- 235000019260 propionic acid Nutrition 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- QLAVPSXZYRYIPC-JTQLQIEISA-N (2s)-2-[2-[4-ethylsulfonyl-3-(trifluoromethyl)phenyl]-4-(trifluoromethyl)phenoxy]propanoic acid Chemical compound C1=C(C(F)(F)F)C(S(=O)(=O)CC)=CC=C1C1=CC(C(F)(F)F)=CC=C1O[C@@H](C)C(O)=O QLAVPSXZYRYIPC-JTQLQIEISA-N 0.000 claims description 2
- WRQIRYJIAFFXPN-VIFPVBQESA-N (2s)-2-[2-[4-methylsulfonyl-3-(trifluoromethyl)phenyl]-4-(trifluoromethyl)phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(C(F)(F)F)C=C1C1=CC=C(S(C)(=O)=O)C(C(F)(F)F)=C1 WRQIRYJIAFFXPN-VIFPVBQESA-N 0.000 claims description 2
- GOZQWZLHIJSPTD-VIFPVBQESA-N (2s)-2-[4-chloro-2-(3-chloro-4-methylsulfonylphenyl)phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C1=CC=C(S(C)(=O)=O)C(Cl)=C1 GOZQWZLHIJSPTD-VIFPVBQESA-N 0.000 claims description 2
- DEFJYXNDIROMLR-UHFFFAOYSA-N 2-[2-(3-fluoro-4-propan-2-ylsulfonylphenyl)-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound C1=C(F)C(S(=O)(=O)C(C)C)=CC=C1C1=CC(C(F)(F)F)=CC=C1OCC(O)=O DEFJYXNDIROMLR-UHFFFAOYSA-N 0.000 claims description 2
- COTOHMPVXMBOHX-UHFFFAOYSA-N 2-[2-[4-ethylsulfonyl-3-(trifluoromethyl)phenyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound C1=C(C(F)(F)F)C(S(=O)(=O)CC)=CC=C1C1=CC(C(F)(F)F)=CC=C1OCC(O)=O COTOHMPVXMBOHX-UHFFFAOYSA-N 0.000 claims description 2
- RTPLFCSOWYFWOG-UHFFFAOYSA-N 2-[4-chloro-2-(3-chloro-4-methylsulfinylphenyl)phenoxy]acetic acid Chemical compound C1=C(Cl)C(S(=O)C)=CC=C1C1=CC(Cl)=CC=C1OCC(O)=O RTPLFCSOWYFWOG-UHFFFAOYSA-N 0.000 claims description 2
- PUKFXDCWBBYHTL-UHFFFAOYSA-N 2-[4-chloro-2-(3-chloro-4-methylsulfonylphenyl)phenoxy]acetic acid Chemical compound C1=C(Cl)C(S(=O)(=O)C)=CC=C1C1=CC(Cl)=CC=C1OCC(O)=O PUKFXDCWBBYHTL-UHFFFAOYSA-N 0.000 claims description 2
- MSJJLHUUPSIOAU-UHFFFAOYSA-N 2-[4-chloro-2-[4-methylsulfonyl-3-(trifluoromethyl)phenyl]phenoxy]acetic acid Chemical compound C1=C(C(F)(F)F)C(S(=O)(=O)C)=CC=C1C1=CC(Cl)=CC=C1OCC(O)=O MSJJLHUUPSIOAU-UHFFFAOYSA-N 0.000 claims description 2
- VZBLMOJEAFVHIR-UHFFFAOYSA-N 2-[4-fluoro-2-[4-methylsulfonyl-3-(trifluoromethyl)phenyl]phenoxy]acetic acid Chemical compound C1=C(C(F)(F)F)C(S(=O)(=O)C)=CC=C1C1=CC(F)=CC=C1OCC(O)=O VZBLMOJEAFVHIR-UHFFFAOYSA-N 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims 15
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 125000005843 halogen group Chemical group 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 230000001404 mediated effect Effects 0.000 claims 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 239000011737 fluorine Substances 0.000 claims 3
- 229910052731 fluorine Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 208000023504 respiratory system disease Diseases 0.000 claims 3
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 claims 2
- 239000001294 propane Substances 0.000 claims 2
- BHMBVRSPMRCCGG-OUTUXVNYSA-N prostaglandin D2 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@@H](O)CC1=O BHMBVRSPMRCCGG-OUTUXVNYSA-N 0.000 claims 2
- BHMBVRSPMRCCGG-UHFFFAOYSA-N prostaglandine D2 Natural products CCCCCC(O)C=CC1C(CC=CCCCC(O)=O)C(O)CC1=O BHMBVRSPMRCCGG-UHFFFAOYSA-N 0.000 claims 2
- 150000003180 prostaglandins Chemical class 0.000 claims 2
- 206010039083 rhinitis Diseases 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- ZWKNQWODTHIBQF-NSHDSACASA-N (2s)-2-[2-[3-fluoro-4-(propan-2-ylcarbamoyl)phenyl]-4-(trifluoromethyl)phenoxy]propanoic acid Chemical compound C1=C(F)C(C(=O)NC(C)C)=CC=C1C1=CC(C(F)(F)F)=CC=C1O[C@@H](C)C(O)=O ZWKNQWODTHIBQF-NSHDSACASA-N 0.000 claims 1
- PTPMTVQCUHVDCM-LBPRGKRZSA-N (2s)-2-[2-[3-fluoro-4-(pyrrolidine-1-carbonyl)phenyl]-4-(trifluoromethyl)phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(C(F)(F)F)C=C1C(C=C1F)=CC=C1C(=O)N1CCCC1 PTPMTVQCUHVDCM-LBPRGKRZSA-N 0.000 claims 1
- CPZCOSTWUZZEBG-AWEZNQCLSA-N (2s)-2-[2-[3-methyl-4-(pyrrolidine-1-carbonyl)phenyl]-4-(trifluoromethyl)phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(C(F)(F)F)C=C1C(C=C1C)=CC=C1C(=O)N1CCCC1 CPZCOSTWUZZEBG-AWEZNQCLSA-N 0.000 claims 1
- PNAULFGEKWYPEQ-LBPRGKRZSA-N (2s)-2-[2-[4-(cyclopentylcarbamoyl)-3-fluorophenyl]-4-(trifluoromethyl)phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(C(F)(F)F)C=C1C(C=C1F)=CC=C1C(=O)NC1CCCC1 PNAULFGEKWYPEQ-LBPRGKRZSA-N 0.000 claims 1
- DUZZYBVTBREVEA-JTQLQIEISA-N (2s)-2-[2-[4-(ethylcarbamoyl)-3-fluorophenyl]-4-(trifluoromethyl)phenoxy]propanoic acid Chemical compound C1=C(F)C(C(=O)NCC)=CC=C1C1=CC(C(F)(F)F)=CC=C1O[C@@H](C)C(O)=O DUZZYBVTBREVEA-JTQLQIEISA-N 0.000 claims 1
- INJYVJAMXPSKEC-NSHDSACASA-N (2s)-2-[2-[4-(tert-butylcarbamoyl)-3-fluorophenyl]-4-(trifluoromethyl)phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(C(F)(F)F)C=C1C1=CC=C(C(=O)NC(C)(C)C)C(F)=C1 INJYVJAMXPSKEC-NSHDSACASA-N 0.000 claims 1
- YYKVKWDQSHNKPS-NSHDSACASA-N (2s)-2-[2-[4-(tert-butylcarbamoyl)-3-fluorophenyl]-4-chlorophenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C1=CC=C(C(=O)NC(C)(C)C)C(F)=C1 YYKVKWDQSHNKPS-NSHDSACASA-N 0.000 claims 1
- QYLONNMSQMJJNU-ZDUSSCGKSA-N (2s)-2-[2-[4-(tert-butylcarbamoyl)-3-methylphenyl]-4-chlorophenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C1=CC=C(C(=O)NC(C)(C)C)C(C)=C1 QYLONNMSQMJJNU-ZDUSSCGKSA-N 0.000 claims 1
- VKPNMMZWRIRSPJ-VIFPVBQESA-N (2s)-2-[4-chloro-2-(3-fluoro-4-methylsulfonylphenyl)phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C1=CC=C(S(C)(=O)=O)C(F)=C1 VKPNMMZWRIRSPJ-VIFPVBQESA-N 0.000 claims 1
- QAZFELYFRXBYRC-LBPRGKRZSA-N (2s)-2-[4-chloro-2-[3-chloro-4-(pyrrolidine-1-carbonyl)phenyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C(C=C1Cl)=CC=C1C(=O)N1CCCC1 QAZFELYFRXBYRC-LBPRGKRZSA-N 0.000 claims 1
- LYJDDJHDTLWGTQ-LBPRGKRZSA-N (2s)-2-[4-chloro-2-[3-fluoro-4-(2-methylbutan-2-ylcarbamoyl)phenyl]phenoxy]propanoic acid Chemical compound C1=C(F)C(C(=O)NC(C)(C)CC)=CC=C1C1=CC(Cl)=CC=C1O[C@@H](C)C(O)=O LYJDDJHDTLWGTQ-LBPRGKRZSA-N 0.000 claims 1
- QUNTXHCQSHNMJD-LBPRGKRZSA-N (2s)-2-[4-chloro-2-[3-fluoro-4-(2-methylpropylcarbamoyl)phenyl]phenoxy]propanoic acid Chemical compound C1=C(F)C(C(=O)NCC(C)C)=CC=C1C1=CC(Cl)=CC=C1O[C@@H](C)C(O)=O QUNTXHCQSHNMJD-LBPRGKRZSA-N 0.000 claims 1
- UXVQKIOREWHLPH-ABLWVSNPSA-N (2s)-2-[4-chloro-2-[3-fluoro-4-(2-methylpyrrolidine-1-carbonyl)phenyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C(C=C1F)=CC=C1C(=O)N1C(C)CCC1 UXVQKIOREWHLPH-ABLWVSNPSA-N 0.000 claims 1
- WLSSFRAXKAMBSN-ZDUSSCGKSA-N (2s)-2-[4-chloro-2-[3-fluoro-4-(3-methylbutylcarbamoyl)phenyl]phenoxy]propanoic acid Chemical compound C1=C(F)C(C(=O)NCCC(C)C)=CC=C1C1=CC(Cl)=CC=C1O[C@@H](C)C(O)=O WLSSFRAXKAMBSN-ZDUSSCGKSA-N 0.000 claims 1
- KKGVTNLDRRNPIP-VIFPVBQESA-N (2s)-2-[4-chloro-2-[3-fluoro-4-(methylcarbamoyl)phenyl]phenoxy]propanoic acid Chemical compound C1=C(F)C(C(=O)NC)=CC=C1C1=CC(Cl)=CC=C1O[C@@H](C)C(O)=O KKGVTNLDRRNPIP-VIFPVBQESA-N 0.000 claims 1
- KJBFQNMNZYJLRO-LBPRGKRZSA-N (2s)-2-[4-chloro-2-[3-fluoro-4-(pentan-3-ylcarbamoyl)phenyl]phenoxy]propanoic acid Chemical compound C1=C(F)C(C(=O)NC(CC)CC)=CC=C1C1=CC(Cl)=CC=C1O[C@@H](C)C(O)=O KJBFQNMNZYJLRO-LBPRGKRZSA-N 0.000 claims 1
- ZGDSPOGGCVOJNC-LBPRGKRZSA-N (2s)-2-[4-chloro-2-[3-fluoro-4-(pyrrolidine-1-carbonyl)phenyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C(C=C1F)=CC=C1C(=O)N1CCCC1 ZGDSPOGGCVOJNC-LBPRGKRZSA-N 0.000 claims 1
- UXVQKIOREWHLPH-OLZOCXBDSA-N (2s)-2-[4-chloro-2-[3-fluoro-4-[(2r)-2-methylpyrrolidine-1-carbonyl]phenyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C(C=C1F)=CC=C1C(=O)N1[C@H](C)CCC1 UXVQKIOREWHLPH-OLZOCXBDSA-N 0.000 claims 1
- UXVQKIOREWHLPH-STQMWFEESA-N (2s)-2-[4-chloro-2-[3-fluoro-4-[(2s)-2-methylpyrrolidine-1-carbonyl]phenyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C(C=C1F)=CC=C1C(=O)N1[C@@H](C)CCC1 UXVQKIOREWHLPH-STQMWFEESA-N 0.000 claims 1
- ZEXZISLAHRBLME-AWEZNQCLSA-N (2s)-2-[4-chloro-2-[3-methyl-4-(pyrrolidine-1-carbonyl)phenyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C(C=C1C)=CC=C1C(=O)N1CCCC1 ZEXZISLAHRBLME-AWEZNQCLSA-N 0.000 claims 1
- ZTQBSOLTFQJYAS-NSHDSACASA-N (2s)-2-[4-chloro-2-[4-(3,3-difluoropyrrolidine-1-carbonyl)-3-fluorophenyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C(C=C1F)=CC=C1C(=O)N1CC(F)(F)CC1 ZTQBSOLTFQJYAS-NSHDSACASA-N 0.000 claims 1
- VXFPYMJHUQOVKG-NSHDSACASA-N (2s)-2-[4-chloro-2-[4-(cyclobutylcarbamoyl)-3-fluorophenyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C(C=C1F)=CC=C1C(=O)NC1CCC1 VXFPYMJHUQOVKG-NSHDSACASA-N 0.000 claims 1
- SEMABQFCWXUGNS-LBPRGKRZSA-N (2s)-2-[4-chloro-2-[4-(cyclopentylcarbamoyl)-3-fluorophenyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C(C=C1F)=CC=C1C(=O)NC1CCCC1 SEMABQFCWXUGNS-LBPRGKRZSA-N 0.000 claims 1
- USAKTMHUVBGRCR-JTQLQIEISA-N (2s)-2-[4-chloro-2-[4-(cyclopropylcarbamoyl)-3-fluorophenyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C(C=C1F)=CC=C1C(=O)NC1CC1 USAKTMHUVBGRCR-JTQLQIEISA-N 0.000 claims 1
- AZIWOMBYWFIQFP-LBPRGKRZSA-N (2s)-2-[4-chloro-2-[4-(diethylcarbamoyl)-3-fluorophenyl]phenoxy]propanoic acid Chemical compound C1=C(F)C(C(=O)N(CC)CC)=CC=C1C1=CC(Cl)=CC=C1O[C@@H](C)C(O)=O AZIWOMBYWFIQFP-LBPRGKRZSA-N 0.000 claims 1
- URAUYNDQINQGIP-JTQLQIEISA-N (2s)-2-[4-chloro-2-[4-(ethylcarbamoyl)-3-fluorophenyl]phenoxy]propanoic acid Chemical compound C1=C(F)C(C(=O)NCC)=CC=C1C1=CC(Cl)=CC=C1O[C@@H](C)C(O)=O URAUYNDQINQGIP-JTQLQIEISA-N 0.000 claims 1
- QFZICZKRDNEFOM-LBPRGKRZSA-N (2s)-2-[4-chloro-2-[4-(pyrrolidine-1-carbonyl)-3-(trifluoromethyl)phenyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C(C=C1C(F)(F)F)=CC=C1C(=O)N1CCCC1 QFZICZKRDNEFOM-LBPRGKRZSA-N 0.000 claims 1
- PRQRONVGMWVYFW-NSHDSACASA-N (2s)-2-[4-chloro-2-[4-[ethyl(methyl)carbamoyl]-3-fluorophenyl]phenoxy]propanoic acid Chemical compound C1=C(F)C(C(=O)N(C)CC)=CC=C1C1=CC(Cl)=CC=C1O[C@@H](C)C(O)=O PRQRONVGMWVYFW-NSHDSACASA-N 0.000 claims 1
- PKRAODYTJMIMTC-LBPRGKRZSA-N (2s)-2-[4-chloro-2-[4-morpholin-4-ylsulfonyl-3-(trifluoromethyl)phenyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1C1=CC=C(S(=O)(=O)N2CCOCC2)C(C(F)(F)F)=C1 PKRAODYTJMIMTC-LBPRGKRZSA-N 0.000 claims 1
- UEQAUTJJFKOVRO-LBPRGKRZSA-N (2s)-2-[4-fluoro-2-[3-fluoro-4-(pyrrolidine-1-carbonyl)phenyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(F)C=C1C(C=C1F)=CC=C1C(=O)N1CCCC1 UEQAUTJJFKOVRO-LBPRGKRZSA-N 0.000 claims 1
- QGHTWZBBNYERQW-UHFFFAOYSA-N 2-[2-[3-fluoro-4-(pyrrolidine-1-carbonyl)phenyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(C(F)(F)F)C=C1C(C=C1F)=CC=C1C(=O)N1CCCC1 QGHTWZBBNYERQW-UHFFFAOYSA-N 0.000 claims 1
- IYXPIDVTZHPTIN-UHFFFAOYSA-N 2-[2-[3-methyl-4-(piperidine-1-carbonyl)phenyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound CC1=CC(C=2C(=CC=C(C=2)C(F)(F)F)OCC(O)=O)=CC=C1C(=O)N1CCCCC1 IYXPIDVTZHPTIN-UHFFFAOYSA-N 0.000 claims 1
- ZMAIHUBEOTZHBC-UHFFFAOYSA-N 2-[2-[3-methyl-4-(pyrrolidine-1-carbonyl)phenyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound CC1=CC(C=2C(=CC=C(C=2)C(F)(F)F)OCC(O)=O)=CC=C1C(=O)N1CCCC1 ZMAIHUBEOTZHBC-UHFFFAOYSA-N 0.000 claims 1
- UKUAESGBUKHDFJ-UHFFFAOYSA-N 2-[4-chloro-2-[3-chloro-4-(1,2-oxazolidine-2-carbonyl)phenyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1C(C=C1Cl)=CC=C1C(=O)N1OCCC1 UKUAESGBUKHDFJ-UHFFFAOYSA-N 0.000 claims 1
- NPWJPUJPPKVZSJ-UHFFFAOYSA-N 2-[4-chloro-2-[3-chloro-4-(2-methylpyrrolidine-1-carbonyl)phenyl]phenoxy]acetic acid Chemical compound CC1CCCN1C(=O)C1=CC=C(C=2C(=CC=C(Cl)C=2)OCC(O)=O)C=C1Cl NPWJPUJPPKVZSJ-UHFFFAOYSA-N 0.000 claims 1
- FNJRYAYRFWBZRU-UHFFFAOYSA-N 2-[4-chloro-2-[3-chloro-4-(morpholine-4-carbonyl)phenyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1C(C=C1Cl)=CC=C1C(=O)N1CCOCC1 FNJRYAYRFWBZRU-UHFFFAOYSA-N 0.000 claims 1
- IUQBGJLTSZXBBC-UHFFFAOYSA-N 2-[4-chloro-2-[3-chloro-4-(pyrrolidine-1-carbonyl)phenyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1C(C=C1Cl)=CC=C1C(=O)N1CCCC1 IUQBGJLTSZXBBC-UHFFFAOYSA-N 0.000 claims 1
- FBTAKDCLJGEXIA-OKILXGFUSA-N 2-[4-chloro-2-[3-chloro-4-[(2r,6s)-2,6-dimethylpiperidine-1-carbonyl]phenyl]phenoxy]acetic acid Chemical compound C[C@H]1CCC[C@@H](C)N1C(=O)C1=CC=C(C=2C(=CC=C(Cl)C=2)OCC(O)=O)C=C1Cl FBTAKDCLJGEXIA-OKILXGFUSA-N 0.000 claims 1
- UINIKFHCWUZECM-UHFFFAOYSA-N 2-[4-chloro-2-[3-fluoro-4-(methylcarbamoyl)phenyl]phenoxy]acetic acid Chemical compound C1=C(F)C(C(=O)NC)=CC=C1C1=CC(Cl)=CC=C1OCC(O)=O UINIKFHCWUZECM-UHFFFAOYSA-N 0.000 claims 1
- YVTWRMXSPMKKFQ-UHFFFAOYSA-N 2-[4-chloro-2-[3-fluoro-4-(pentan-3-ylcarbamoyl)phenyl]phenoxy]acetic acid Chemical compound C1=C(F)C(C(=O)NC(CC)CC)=CC=C1C1=CC(Cl)=CC=C1OCC(O)=O YVTWRMXSPMKKFQ-UHFFFAOYSA-N 0.000 claims 1
- RMIBAADHMKOWOK-UHFFFAOYSA-N 2-[4-chloro-2-[3-fluoro-4-(pyrrolidine-1-carbonyl)phenyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1C(C=C1F)=CC=C1C(=O)N1CCCC1 RMIBAADHMKOWOK-UHFFFAOYSA-N 0.000 claims 1
- IIIFXYGIHLFDHY-UHFFFAOYSA-N 2-[4-chloro-2-[3-methyl-4-(pyrrolidine-1-carbonyl)phenyl]phenoxy]acetic acid Chemical compound CC1=CC(C=2C(=CC=C(Cl)C=2)OCC(O)=O)=CC=C1C(=O)N1CCCC1 IIIFXYGIHLFDHY-UHFFFAOYSA-N 0.000 claims 1
- XGNDSMFJXIJWAG-UHFFFAOYSA-N 2-[4-chloro-2-[4-(pyrrolidine-1-carbonyl)-3-(trifluoromethyl)phenyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1C(C=C1C(F)(F)F)=CC=C1C(=O)N1CCCC1 XGNDSMFJXIJWAG-UHFFFAOYSA-N 0.000 claims 1
- ZWJVAEZKJLVHFK-UHFFFAOYSA-N 2-[4-chloro-2-[4-ethylsulfonyl-3-(trifluoromethyl)phenyl]phenoxy]acetic acid Chemical compound C1=C(C(F)(F)F)C(S(=O)(=O)CC)=CC=C1C1=CC(Cl)=CC=C1OCC(O)=O ZWJVAEZKJLVHFK-UHFFFAOYSA-N 0.000 claims 1
- GMDOLYPALLGUNC-UHFFFAOYSA-N 2-[4-chloro-2-[4-morpholin-4-ylsulfonyl-3-(trifluoromethyl)phenyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1C1=CC=C(S(=O)(=O)N2CCOCC2)C(C(F)(F)F)=C1 GMDOLYPALLGUNC-UHFFFAOYSA-N 0.000 claims 1
- RFBBFKLHURYFQQ-UHFFFAOYSA-N 2-[4-fluoro-2-[3-fluoro-4-(pyrrolidine-1-carbonyl)phenyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(F)C=C1C(C=C1F)=CC=C1C(=O)N1CCCC1 RFBBFKLHURYFQQ-UHFFFAOYSA-N 0.000 claims 1
- -1 [[4 ′-(1-azetinidylcarbonyl) -3 ′, 5-dichloro [1,1′-biphenyl] -2-yl] oxy] -acetic acid Chemical compound 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- 0 *C(*)(C(O)=O)Oc1ccc(*)cc1-c1cc(*)c(*)cc1* Chemical compound *C(*)(C(O)=O)Oc1ccc(*)cc1-c1cc(*)c(*)cc1* 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 206010061289 metastatic neoplasm Diseases 0.000 description 2
- ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 2
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- KOUOVRBERGDLTB-UHFFFAOYSA-N CC(C(O)=O)Oc(c(-c(c(F)c1)cc(F)c1S(N1CCOCC1)(=O)=O)c1)ccc1Cl Chemical compound CC(C(O)=O)Oc(c(-c(c(F)c1)cc(F)c1S(N1CCOCC1)(=O)=O)c1)ccc1Cl KOUOVRBERGDLTB-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000017604 Hodgkin disease Diseases 0.000 description 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000001589 lymphoproliferative effect Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 208000029522 neoplastic syndrome Diseases 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0418830.6A GB0418830D0 (en) | 2004-08-24 | 2004-08-24 | Novel compounds |
| GB0418830.6 | 2004-08-24 | ||
| PCT/GB2005/003255 WO2006021759A1 (en) | 2004-08-24 | 2005-08-22 | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008510778A JP2008510778A (ja) | 2008-04-10 |
| JP2008510778A5 true JP2008510778A5 (https=) | 2008-10-09 |
| JP4990773B2 JP4990773B2 (ja) | 2012-08-01 |
Family
ID=33042538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007528960A Expired - Fee Related JP4990773B2 (ja) | 2004-08-24 | 2005-08-22 | 呼吸器疾患の処置のためのビフェニルオキシ酢酸誘導体 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US7737135B2 (https=) |
| EP (1) | EP1784388B3 (https=) |
| JP (1) | JP4990773B2 (https=) |
| KR (1) | KR20070047319A (https=) |
| CN (1) | CN101048369B (https=) |
| AR (1) | AR053092A1 (https=) |
| AT (1) | ATE447551T1 (https=) |
| AU (1) | AU2005276281A1 (https=) |
| BR (1) | BRPI0514448A (https=) |
| CA (1) | CA2575200A1 (https=) |
| DE (1) | DE602005017503D1 (https=) |
| ES (1) | ES2335425T7 (https=) |
| GB (1) | GB0418830D0 (https=) |
| IL (1) | IL181049A0 (https=) |
| MX (1) | MX2007002095A (https=) |
| NO (1) | NO20071577L (https=) |
| RU (1) | RU2007106039A (https=) |
| TW (1) | TW200621690A (https=) |
| UY (1) | UY29079A1 (https=) |
| WO (1) | WO2006021759A1 (https=) |
| ZA (1) | ZA200701584B (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0301009D0 (sv) * | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
| SE0301010D0 (sv) * | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
| SA04250253B1 (ar) | 2003-08-21 | 2009-11-10 | استرازينيكا ايه بي | احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن |
| GB0415320D0 (en) | 2004-07-08 | 2004-08-11 | Astrazeneca Ab | Novel compounds |
| GB0418830D0 (en) * | 2004-08-24 | 2004-09-22 | Astrazeneca Ab | Novel compounds |
| GB0422057D0 (en) * | 2004-10-05 | 2004-11-03 | Astrazeneca Ab | Novel compounds |
| UY29223A1 (es) | 2004-11-23 | 2006-06-30 | Astrazeneca Ab | Ácidos fenoxiacéticos sustituidos, composiciones farmacéuticas que los contienen y procesos para su preparación |
| WO2007010350A1 (en) * | 2005-07-19 | 2007-01-25 | Pfizer Products Inc. | Synthesis of therapeutic diphenyl ethers |
| EP1937632A1 (en) | 2005-10-06 | 2008-07-02 | Astra Zeneca AB | Novel compounds |
| TW200745003A (en) | 2005-10-06 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
| EP1948630A2 (en) * | 2005-11-05 | 2008-07-30 | AstraZeneca AB | Novel compounds |
| TW200732296A (en) * | 2005-12-15 | 2007-09-01 | Astrazeneca Ab | Novel compounds |
| UA100983C2 (ru) * | 2007-07-05 | 2013-02-25 | Астразенека Аб | Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты |
| RU2010116821A (ru) * | 2007-10-01 | 2011-11-10 | Ф.Хоффманн-Ля Аг (Ch) | N-гетероциклические биарильные карбоксамиды в качестве антагонистов рецептора ccr |
| GB0720389D0 (en) | 2007-10-18 | 2008-11-12 | Prosidion Ltd | G-Protein Coupled Receptor Agonists |
| CN102958914B (zh) | 2010-07-05 | 2015-05-27 | 埃科特莱茵药品有限公司 | 1-苯基取代的杂环衍生物及其作为前列腺素d2受体调节剂的用途 |
| EP2457900A1 (en) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | New pyrazole derivatives having CRTh2 antagonistic behaviour |
| SG11201402796SA (en) | 2011-12-16 | 2014-06-27 | Atopix Therapeutics Ltd | Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis |
| TW201331179A (zh) | 2011-12-21 | 2013-08-01 | Actelion Pharmaceuticals Ltd | 雜環衍生物及其作為前列腺素ｄ２受體調節劑之用途 |
| CA2876808A1 (en) | 2012-07-05 | 2014-01-09 | Actelion Pharmaceuticals Ltd | 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| US12440477B2 (en) | 2017-12-14 | 2025-10-14 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
| US10513504B2 (en) | 2018-03-08 | 2019-12-24 | Apotex Inc. | Processes for the preparation of apalutamide and intermediates thereof |
| WO2021220137A2 (en) * | 2020-04-27 | 2021-11-04 | Sapir Pharmaceuticals Inc. | Pannexin-1 inhibitors for the treatment of sars-cov-2 infected covid-19 patients with or without an associated acute respiratory syndrome |
| CN115197084A (zh) * | 2022-07-11 | 2022-10-18 | 中国船舶重工集团公司第七一八研究所 | 一种恩杂鲁胺关键中间体的制备方法 |
Family Cites Families (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB690816A (en) | 1950-01-02 | 1953-04-29 | British Drug Houses Ltd | Improvements in or relating to the manufacture of substituted phenoxy acetic acids |
| US3278524A (en) | 1962-03-13 | 1966-10-11 | Beecham Group Ltd | Penicillins and their production |
| CH432119A (de) | 1963-02-22 | 1967-03-15 | Geigy Ag J R | Verwendung von Halogen-o-hydroxy-diphenyläthern als antimikrobielle Mittel |
| BE790679A (fr) | 1971-11-03 | 1973-04-27 | Ici Ltd | Derives de l'indole |
| DD113545A5 (https=) | 1973-03-30 | 1975-06-12 | ||
| JPS5239888B2 (https=) | 1973-05-28 | 1977-10-07 | ||
| US3954852A (en) * | 1973-10-19 | 1976-05-04 | Merck & Co., Inc. | Indenylacetic acid compounds |
| CH582476A5 (https=) | 1973-10-29 | 1976-12-15 | Ciba Geigy Ag | |
| SE419538B (sv) * | 1973-10-29 | 1981-08-10 | Eisai Co Ltd | Analogiforfaranden for framstellning av 2-(n-fenoxfenyl)-propionsyraderivat |
| GB1585963A (en) | 1976-10-14 | 1981-03-11 | Lilly Industries Ltd | Aryl sulphur compounds |
| US4248618A (en) * | 1977-05-06 | 1981-02-03 | Ici Australia Limited | Derivatives of (pyrimidyloxy)phenoxy-alkanecarboxylic acid and herbicidal compositions thereof |
| FR2428629A1 (fr) | 1978-06-14 | 1980-01-11 | Hexachimie | Nouveaux composes bis(aryloxycarboxyliques), leur preparation et leur utilisation en therapeutique |
| JPS5951943B2 (ja) | 1978-08-21 | 1984-12-17 | キツセイ薬品工業株式会社 | 新規なイミダゾ−ル誘導体 |
| GB2041363B (en) | 1979-01-19 | 1982-10-06 | Pfizer Ltd | N-benzyl-imidazoles |
| US4670566A (en) | 1979-07-12 | 1987-06-02 | A. H. Robins Company, Incorporated | 3-methyl-hio-4-(5-, 6-, or 7-)phenylindolindolin-2-ones |
| US4486593A (en) | 1983-01-19 | 1984-12-04 | The Upjohn Company | 2-,3-, or 4-Pyridinylmethylamino arylic acids as thromboxane A2 synthetase and 5-lipoxygenase inhibitors |
| US5006542A (en) * | 1988-10-31 | 1991-04-09 | E. R. Squibb & Sons, Inc. | Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same and method of use |
| US5145790A (en) | 1990-05-04 | 1992-09-08 | Abbott Laboratories | Reagents and method for detecting polychlorinated biphenyls |
| EP0540165A1 (en) | 1991-10-03 | 1993-05-05 | Zeneca Limited | Alkanoic acid derivatives |
| WO1993012086A1 (fr) | 1991-12-11 | 1993-06-24 | Ss Pharmaceutical Co., Ltd. | Derive d'arylamide |
| CA2090283A1 (en) | 1992-02-28 | 1993-08-29 | Nobuyuki Hamanaka | Phenoxyacetic acid derivatives |
| EP0607536B1 (en) * | 1992-12-08 | 2001-01-24 | Ss Pharmaceutical Co., Ltd. | Arylamide derivatives |
| JPH06313995A (ja) | 1993-04-28 | 1994-11-08 | Hodogaya Chem Co Ltd | 静電荷像現像用トナー |
| EP0622816B1 (en) | 1993-04-30 | 1998-07-22 | Kabushiki Kaisha Meidensha | Electrode and process for forming an electrode material |
| JPH07140725A (ja) | 1993-06-25 | 1995-06-02 | Hodogaya Chem Co Ltd | 負帯電性トナー用摩擦帯電付与部材 |
| JPH11512095A (ja) | 1995-08-28 | 1999-10-19 | アメリカン・ホーム・プロダクツ・コーポレイション | アルドース還元酵素阻害薬および抗高血糖症薬としてのフェノキシ酢酸 |
| DE19544828A1 (de) * | 1995-12-01 | 1997-06-05 | Hoechst Ag | Hochmolekulare Copolymere |
| JP2001505869A (ja) | 1996-07-22 | 2001-05-08 | モンサント カンパニー | チオールスルホン メタロプロテアーゼ阻害剤 |
| CA2219269A1 (en) | 1996-10-29 | 1998-04-29 | Novartis Ag | Novel herbicides |
| FR2763588B1 (fr) * | 1997-05-23 | 1999-07-09 | Cird Galderma | Composes triaromatiques, compositions les contenant et utilisations |
| CO4960662A1 (es) | 1997-08-28 | 2000-09-25 | Novartis Ag | Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados |
| US5942532A (en) | 1997-09-05 | 1999-08-24 | Ortho Pharmaceutical Corporation | 2-substituted phenyl-benzimidazole antibacterial agents |
| CA2301742C (en) | 1997-09-12 | 2004-05-18 | Richard Friesen | 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2 |
| US6376546B1 (en) | 1997-10-14 | 2002-04-23 | Asahi Kasei Kabushiki Kaisha | Biphenyl-5-alkanoic acid derivatives and use thereof |
| WO2001014882A1 (fr) | 1999-08-23 | 2001-03-01 | Bml, Inc. | Identification des proprietes d'une substance pour les recepteurs de prostaglandine d |
| US6417212B1 (en) | 1999-08-27 | 2002-07-09 | Eli Lilly & Company | Modulators of peroxisome proliferator activated receptors |
| JP2003523336A (ja) | 2000-02-18 | 2003-08-05 | メルク エンド カムパニー インコーポレーテッド | 糖尿病及び脂質障害のためのアリールオキシ酢酸 |
| WO2001081312A2 (en) | 2000-04-24 | 2001-11-01 | Merck Frosst Canada & Co. | Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| AU2001258628A1 (en) | 2000-05-31 | 2001-12-11 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| JP2004501191A (ja) * | 2000-06-28 | 2004-01-15 | テバ ファーマシューティカル インダストリーズ リミティド | カルベジロール |
| US6878522B2 (en) | 2000-07-07 | 2005-04-12 | Baiyong Li | Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
| US20040097555A1 (en) * | 2000-12-26 | 2004-05-20 | Shinegori Ohkawa | Concomitant drugs |
| EP1395257A1 (en) * | 2001-06-12 | 2004-03-10 | Elan Pharmaceuticals, Inc. | Macrocycles useful in the treatment of alzheimer's disease |
| CA2459515A1 (en) | 2001-09-07 | 2003-03-20 | Kazuhiko Torisu | Indole derivatives |
| RU2337909C2 (ru) | 2002-02-01 | 2008-11-10 | Ф.Хоффманн-Ля Рош Аг | Замещенные индолы и фармацевтическая композиция, обладающая агонистической активностью в отношении альфа-1a/l адренорецептора |
| SE0200411D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
| AU2003211427A1 (en) | 2002-02-18 | 2003-09-04 | Ishihara Sangyo Kaisha, Ltd. | Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same |
| CA2479338A1 (en) | 2002-03-20 | 2003-10-02 | Metabolex, Inc. | Substituted phenylacetic acids |
| WO2003097042A1 (en) | 2002-05-16 | 2003-11-27 | Shionogi & Co., Ltd. | Pgd2 receptor antagonist |
| AU2003231509A1 (en) | 2002-05-16 | 2003-12-02 | Shionogi And Co., Ltd. | Compound exhibiting pgd 2 receptor antagonism |
| SE0201635D0 (sv) | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
| SE0202241D0 (sv) | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
| PE20040844A1 (es) | 2002-11-26 | 2004-12-30 | Novartis Ag | Acidos fenilaceticos y derivados como inhibidores de la cox-2 |
| PL377314A1 (pl) | 2002-12-20 | 2006-01-23 | Amgen Inc. | Modulatory astmy i zapaleń na tle alergicznym |
| WO2004094386A1 (en) * | 2003-03-28 | 2004-11-04 | Eli Lilly And Company | Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b) |
| SE0301009D0 (sv) | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
| SE0301010D0 (sv) | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
| PT1471057E (pt) | 2003-04-25 | 2006-05-31 | Actimis Pharmaceuticals Inc | Derivados de acido pirimidinilacetico uteis para o tratamento de doencas mediadas por crth2 |
| SA04250253B1 (ar) | 2003-08-21 | 2009-11-10 | استرازينيكا ايه بي | احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن |
| GB0324763D0 (en) | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
| US7166738B2 (en) | 2004-04-23 | 2007-01-23 | Roche Palo Alto Llc | Non-nucleoside reverse transcriptase inhibitors |
| GB0409921D0 (en) | 2004-05-04 | 2004-06-09 | Novartis Ag | Organic compounds |
| EP1758579A1 (en) | 2004-05-29 | 2007-03-07 | 7TM Pharma A/S | Crth2 receptor ligands for medicinal uses |
| GB0415320D0 (en) | 2004-07-08 | 2004-08-11 | Astrazeneca Ab | Novel compounds |
| GB0418830D0 (en) | 2004-08-24 | 2004-09-22 | Astrazeneca Ab | Novel compounds |
| GB0422057D0 (en) | 2004-10-05 | 2004-11-03 | Astrazeneca Ab | Novel compounds |
| UY29223A1 (es) | 2004-11-23 | 2006-06-30 | Astrazeneca Ab | Ácidos fenoxiacéticos sustituidos, composiciones farmacéuticas que los contienen y procesos para su preparación |
| GB0510584D0 (en) | 2005-05-24 | 2005-06-29 | Novartis Ag | Organic compounds |
| EP1937632A1 (en) | 2005-10-06 | 2008-07-02 | Astra Zeneca AB | Novel compounds |
| TW200745003A (en) | 2005-10-06 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
| EP1948630A2 (en) | 2005-11-05 | 2008-07-30 | AstraZeneca AB | Novel compounds |
| TW200732296A (en) | 2005-12-15 | 2007-09-01 | Astrazeneca Ab | Novel compounds |
| UA100983C2 (ru) | 2007-07-05 | 2013-02-25 | Астразенека Аб | Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты |
-
2004
- 2004-08-24 GB GBGB0418830.6A patent/GB0418830D0/en not_active Ceased
-
2005
- 2005-08-19 AR ARP050103487A patent/AR053092A1/es unknown
- 2005-08-22 BR BRPI0514448-5A patent/BRPI0514448A/pt not_active Application Discontinuation
- 2005-08-22 ES ES05773308T patent/ES2335425T7/es active Active
- 2005-08-22 MX MX2007002095A patent/MX2007002095A/es not_active Application Discontinuation
- 2005-08-22 CA CA002575200A patent/CA2575200A1/en not_active Abandoned
- 2005-08-22 EP EP05773308A patent/EP1784388B3/en not_active Expired - Lifetime
- 2005-08-22 DE DE602005017503T patent/DE602005017503D1/de not_active Expired - Lifetime
- 2005-08-22 CN CN2005800364721A patent/CN101048369B/zh not_active Expired - Fee Related
- 2005-08-22 AU AU2005276281A patent/AU2005276281A1/en not_active Abandoned
- 2005-08-22 RU RU2007106039/04A patent/RU2007106039A/ru unknown
- 2005-08-22 JP JP2007528960A patent/JP4990773B2/ja not_active Expired - Fee Related
- 2005-08-22 US US11/574,076 patent/US7737135B2/en not_active Expired - Fee Related
- 2005-08-22 WO PCT/GB2005/003255 patent/WO2006021759A1/en not_active Ceased
- 2005-08-22 AT AT05773308T patent/ATE447551T1/de not_active IP Right Cessation
- 2005-08-22 KR KR1020077004365A patent/KR20070047319A/ko not_active Withdrawn
- 2005-08-23 UY UY29079A patent/UY29079A1/es not_active Application Discontinuation
- 2005-08-23 TW TW094128765A patent/TW200621690A/zh unknown
-
2007
- 2007-01-29 IL IL181049A patent/IL181049A0/en unknown
- 2007-02-22 ZA ZA200701584A patent/ZA200701584B/xx unknown
- 2007-03-26 NO NO20071577A patent/NO20071577L/no not_active Application Discontinuation
-
2009
- 2009-12-18 US US12/642,244 patent/US8163727B2/en not_active Expired - Fee Related
-
2011
- 2011-12-06 US US13/311,647 patent/US8722741B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008510778A5 (https=) | ||
| TWI311551B (en) | Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids | |
| CA2816093C (en) | Compounds and compositions for the treatment of cancer | |
| AU770642B2 (en) | Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity | |
| JP2010528089A5 (https=) | ||
| JP2021530565A5 (https=) | ||
| JP6810275B2 (ja) | ３−フェニル−２，３，４，８，９，１０−ヘキサヒドロピラノ［２，３−ｆ］クロメン誘導体およびその光学異性体の合成方法 | |
| JP2005524605A5 (https=) | ||
| JP2015509098A5 (https=) | ||
| RU2007106039A (ru) | Производные бифенилоксиуксусной кислоты для лечения респираторного заболевания | |
| JP2023027160A (ja) | ＮｏｔｃｈシグナリングのエンハンサーならびにＮｏｔｃｈのアップレギュレーションにより治療可能ながんおよび悪性腫瘍の治療におけるその使用 | |
| JP2016505058A5 (https=) | ||
| JP2023510746A5 (https=) | ||
| JP2020521732A5 (https=) | ||
| JP2014511897A5 (https=) | ||
| JP4026076B2 (ja) | 選択性の優れたシクロオキシゲナーゼ−２の阻害剤としての４’−メタンスルホニル−ビフェニル誘導体 | |
| JP2024517443A5 (https=) | ||
| EA016767B1 (ru) | Ретиноидное пролекарственное соединение | |
| CN111728962B (zh) | 白藜芦醇衍生物及其抗纤维化的医药用途 | |
| JP2018043952A (ja) | 抗腫瘍薬およびこれを含む組成物 | |
| KR20140011383A (ko) | 치환된 디페닐 유도체 | |
| JPH02229168A (ja) | ピラゾロン誘導体 | |
| CN108473449B (zh) | 一种作为吲哚胺-2,3-双加氧酶抑制剂的砜脒及其制备方法和用途 | |
| TWI811116B (zh) | 含硒元素的查爾酮化合物及其製備方法、包含其的醫藥組合物、以及用於製備預防或治療大腸癌之醫藥組合物的用途 | |
| JP2013503170A5 (https=) |